Ckd Bio (063160) — Cash Flow Quality Index
Ckd Bio (063160) has a Cash Flow Quality Index of -5.50x as of March 2025. Operating cash flow of ₩-4.95 Billion is below net income of ₩900.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Ckd Bio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ckd Bio Cash Flow Quality Index (2008–2024)
Historical Cash Flow Quality Index for Ckd Bio across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Ckd Bio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Ckd Bio (2008–2024)
Year-by-year earnings quality comparison for Ckd Bio. For live market cap and the full company financial profile, see how much is Ckd Bio worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.61x | ₩14.03 Billion | ₩8.70 Billion | ▲ +107.5% |
| 2020 | 0.78x | ₩4.82 Billion | ₩6.21 Billion | ▼ -43.9% |
| 2019 | 1.39x | ₩16.99 Billion | ₩12.26 Billion | ▼ -29.1% |
| 2018 | 1.95x | ₩15.54 Billion | ₩7.96 Billion | ▼ -23.4% |
| 2017 | 2.55x | ₩20.45 Billion | ₩8.02 Billion | ▲ +55.2% |
| 2016 | 1.64x | ₩15.50 Billion | ₩9.43 Billion | ▼ -23.8% |
| 2015 | 2.16x | ₩14.34 Billion | ₩6.65 Billion | ▼ -67.3% |
| 2013 | 6.59x | ₩10.92 Billion | ₩1.66 Billion | ▲ +104.4% |
| 2012 | 3.22x | ₩22.90 Billion | ₩7.10 Billion | ▲ +171.7% |
| 2011 | 1.19x | ₩12.96 Billion | ₩10.92 Billion | ▼ -28.6% |
| 2010 | 1.66x | ₩23.89 Billion | ₩14.38 Billion | ▲ +1.2% |
| 2009 | 1.64x | ₩26.57 Billion | ₩16.18 Billion | ▲ +34.2% |
| 2008 | 1.22x | ₩10.69 Billion | ₩8.74 Billion | — |